ClassID:

96898

C07K14/47 - page 8 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Recent Application in this class:
#2101
20180072811
2018-03-15

Anti-CSPG4 reagents and methods of treating cancer

#2102
20180072783
2018-03-15

Polynucleotides encoding angiopoietin-2 (ang-2) binding polypeptides

#2103
20180072782
2018-03-15

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

#2104
20180071655
2018-03-15

Adsorbent for chromatographic separation of proteins

#2105
20180071363
2018-03-15

Alpha connexin c-terminal (ACT) peptides and methods of use thereof

#2106
20180066286
2018-03-08

NUCLEAR TARGETING SEQUENCES

#2107
20180066266
2018-03-08

EML4-ALK FUSION GENE

#2108
20180066030
2018-03-08

Method of treating vitiligo using mutant HSP70i

#2109
20180066028
2018-03-08

Muteins of a1m lipocalin and method of production therefor

#2110
20180064827
2018-03-08

Modulation of liver genes

#2111
20180064792
2018-03-08

IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE

#2112
20180057838
2018-03-01

Synthetic transcriptional and epigenetic regulators based on engineered, orthogonal zinc finger proteins

#2113
20180057563
2018-03-01

Methods for expanding immune cells

#2114
20180055768
2018-03-01

ARRDC1-mediated microvesicles (ARMMS) and uses thereof

#2115
20180051298
2018-02-22

Efficient non-meiotic allele introgression

#2116
20180051262
2018-02-22

Messenger UNA molecules and uses thereof

#2117
20180051060
2018-02-22

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#2118
20180051059
2018-02-22

Controlled gene expression methods

#2119
20180050117
2018-02-22

Methods and pharmaceutical composition for the treatment and the prevention of neurological phenotype associated with Friedreich ataxia

#2120
20180045742
2018-02-15

Development and use of cysteine-labeled fluorescent probes of unbound analytes

#2121
20180045741
2018-02-15

BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF

#2122
20180045729
2018-02-15

Mutant smoothened and methods of using the same

#2123
20180044409
2018-02-15

Antibody-mediated transduction of heat shock proteins into living cells

#2124
20180044388
2018-02-15

Opsin polypeptides and methods of use thereof

#2125
20180044387
2018-02-15

SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE

#2126
20180037929
2018-02-08

Sampler and method of parameterizing of digital circuits and of non-invasive determination of the concentration of several biomarkers simultaneously and in real time

#2127
20180037871
2018-02-08

CANCER INITIATING CELL AND USE THEREOF

#2128
20180037629
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#2129
20180037628
2018-02-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#2130
20180037627
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#2131
20180037626
2018-02-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#2132
20180037621
2018-02-08

Compositions and methods for enhancing an immune response

#2133
20180037619
2018-02-08

Proteins specific for pyoverdine and pyochelin

#2134
20180037618
2018-02-08

Proteins specific for pyoverdine and pyochelin

#2135
20180037617
2018-02-08

Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins

#2136
20180037610
2018-02-08

SP-B and SP-C peptides, synthetic lung surfactants, and use thereof

#2137
20180037607
2018-02-08

Peptides for the treatment of malignant proliferative diseases

#2138
20180036431
2018-02-08

DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9

#2139
20180030536
2018-02-01

Gene and mutations thereof associated with seizure and movement disorders

#2140
20180030152
2018-02-01

FUSION PROTEINS AND METHODS THEREOF

#2141
20180030148
2018-02-01

COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES

#2142
20180030134
2018-02-01

Inhibitors of T-cell activation

#2143
20180030125
2018-02-01

Device and method for detecting a target analyte

#2144
20180030113
2018-02-01

Peptides and combination of peptides for use in immunotherapy against various tumors

#2145
20180030101
2018-02-01

Proteins specific for pyoverdine and pyochelin

#2146
20180030099
2018-02-01

Apelin Fusion Proteins and Uses Thereof

#2147
20180028833
2018-02-01

Recombinant self-assembling protein comprising target-oriented peptide and use thereof

#2148
20180028599
2018-02-01

MCJ agonists and uses therefor

#2149
20180021418
2018-01-25

Engineered T cells and uses therefor

#2150
20180021364
2018-01-25

CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES

#2151
20180016612
2018-01-18

Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates

#2152
20180016313
2018-01-18

Modified DKK2 protein, nucleic acid encoding the same, preparation method thereof, and use thereof

#2153
20180016312
2018-01-18

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof

#2154
20180009864
2018-01-11

Synthetic promoters for high throughput screening and gene modulation

#2155
20180009858
2018-01-11

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#2156
20180009854
2018-01-11

Non-natural consensus albumin binding domains

#2157
20180002718
2018-01-04

WISE/SOST NUCLEIC ACID SEQUENCES AND AMINO ACID SEQUENCES

#2158
20180002661
2018-01-04

Compositions of active WNT protein

#2159
20180002409
2018-01-04

Human Anti-Tau Antibodies

#2160
20180002393
2018-01-04

Modified polynucleotides for the production of oncology-related proteins and peptides

#2161
20180002388
2018-01-04

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

#2162
20180000906
2018-01-04

MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF

#2163
20170370917
2017-12-28

MOLECULAR SENSORS

#2164
20170369867
2017-12-28

Mirac proteins

#2165
20170369543
2017-12-28

METHODS AND REAGENTS FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION

#2166
20170369542
2017-12-28

HUMAN NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (HNGAL) MUTEINS THAT BIND HEPCIDIN AND NUCLEIC ACID ENCODING SUCH

#2167
20170369541
2017-12-28

Methods to produce rod-derived cone viability factor (RDCVF)

#2168
20170368200
2017-12-28

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

#2169
20170368138
2017-12-28

Method of treating cancer with a multiple integrin binding Fc fusion protein

#2170
20170368084
2017-12-28

Method for enhancing immunity using ginsenoside F1 as an active ingredient

#2171
20170362660
2017-12-21

CEREBLON ISOFORMS AND THEIR USE AS BIOMARKERS FOR THERAPEUTIC TREATMENT

#2172
20170362624
2017-12-21

LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS

#2173
20170362582
2017-12-21

Cytotoxic molecules responsive to intracellular ligands for selective T cell mediated killing

#2174
20170360949
2017-12-21

Polypeptide complex of titin-telethonin beta-pleated sheet structure as polypeptide drug carrier, method of using the polypeptide complex, and fusion protein complex thereof

#2175
20170360911
2017-12-21

Tumor antigen peptide

#2176
20170360886
2017-12-21

Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide

#2177
20170356023
2017-12-14

Use of eRF1 mutants in unnatural amino acid incorporation

#2178
20170355977
2017-12-14

Optogenetic tool for rapid and reversible clustering of proteins

#2179
20170355755
2017-12-14

COMPOSITIONS AND METHODS FOR MODULATING SALM5 AND HVEM

#2180
20170355752
2017-12-14

COLON DISEASE TARGETS AND USES THEREOF

#2181
20170355734
2017-12-14

Metabolically Stable Apelin Analogs in the Treatment of Disease Mediated by the Apelin Receptor

#2182
20170354720
2017-12-14

Class of therapeutic protein based molecules

#2183
20170350897
2017-12-07

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES

#2184
20170350879
2017-12-07

Long term hematopoietic stem cell specific reporter mouse and uses thereof

#2185
20170349638
2017-12-07

COMPANION DIAGNOSTIC TOOL FOR PEPTIDOMIMETIC MACROCYCLES

#2186
20170348436
2017-12-07

In vivo production of proteins

#2187
20170348387
2017-12-07

AAV-MEDIATED GENE THERAPY FOR NPHP5 LCA-CILIOPATHY

#2188
20170343570
2017-11-30

MT-45 IMMUNODETECTION

#2189
20170343539
2017-11-30

Nucleic acid constructs and methods for labeling and detecting nucleosomal DNA modifications

#2190
20170342434
2017-11-30

Chloroplast Expressing Colostrum or Milk Polypeptides

#2191
20170342118
2017-11-30

Methods and compositions for treating hemophilia

#2192
20170342117
2017-11-30

Ghrelin splice variant for treating neuronal damage, neurodegenerative disease, parkinsons disease, alzheimers disease, and/or depression

#2193
20170340754
2017-11-30

Efficient delivery of therapeutic molecules in vitro and in vivo

#2194
20170340737
2017-11-30

Interleukin-13 binding proteins

#2195
20170340703
2017-11-30

Tear lipocalin muteins binding IL-4 R alpha

#2196
20170335311
2017-11-23

CHIMERIC PROTEIN

#2197
20170335015
2017-11-23

Bi-specific fusion proteins

#2198
20170334960
2017-11-23

Methods and compositions for delivering interleukin-1 receptor antagonist

#2199
20170334959
2017-11-23

Protoxin-II variants and methods of use

#2200
20170334958
2017-11-23

PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS

#2201
20170328886
2017-11-16

SYSTEMS AND METHODS FOR DETERMINING THERAPEUTIC UPTAKE AND DOSING

#2202
20170327850
2017-11-16

ENGINEERED FUNGI FOR ITACONIC ACID PRODUCTION

#2203
20170327848
2017-11-16

Artificial nucleases comprising engineered cleavage half-domains

#2204
20170327560
2017-11-16

GDF15 fusion proteins and uses thereof

#2205
20170327557
2017-11-16

Efficient delivery of therapeutic molecules to cells of the inner ear

#2206
20170327556
2017-11-16

CARTILAGE-BINDING FUSION PROTEINS

#2207
20170327552
2017-11-16

Peptides and compositions for treatment of joint damage

#2208
20170327550
2017-11-16

NBP158 and uses thereof

#2209
20170327548
2017-11-16

Charged Nutritive Fragments, Proteins and Methods

#2210
20170326257
2017-11-16

Satiation peptides for weight loss and altered taste sensitivity

#2211
20170322221
2017-11-09

PREDICTION MARKER

#2212
20170321205
2017-11-09

Ubiquitin variant modulators of SCF E3 ligases and their uses

#2213
20170320968
2017-11-09

METHODS AND PRODUCTS FOR INCREASING FRATAXIN LEVELS AND USES THEREOF

#2214
20170320963
2017-11-09

Genetic products differentially expressed in tumors and the use thereof

#2215
20170320933
2017-11-09

Cytokine-based fusion proteins for treatment of immune disorders

#2216
20170320917
2017-11-09

Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway

#2217
20170319671
2017-11-09

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

#2218
20170314027
2017-11-02

INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION

#2219
20170313988
2017-11-02

METHODS AND AGENTS FOR CELLUALR REPROGRAMMING

#2220
20170313760
2017-11-02

Peptides and combination of peptides for use in immunotherapy against various tumors

#2221
20170313750
2017-11-02

Selective PYY compounds and uses thereof

#2222
20170313748
2017-11-02

Capping modules for designed ankyrin repeat proteins

#2223
20170312332
2017-11-02

Inhibitors of mitochondrial fission and methods of use thereof

#2224
20170305997
2017-10-26

EGFR and c-Met fibronectin type III domain binding molecules

#2225
20170305993
2017-10-26

Peptides and combination of peptides for use in immunotherapy against various tumors

#2226
20170305992
2017-10-26

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#2227
20170305982
2017-10-26

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

#2228
20170305981
2017-10-26

SYNTHETIC PEPTIDES

#2229
20170305980
2017-10-26

CA125 GENE AND ITS USE FOR DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS

#2230
20170304465
2017-10-26

Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma

#2231
20170304457
2017-10-26

Artificially engineered protein hydrogels to mimic nucleoporin selective gating

#2232
20170304432
2017-10-26

NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES

#2233
20170304384
2017-10-26

Substances and methods for the use in prevention and/or treatment in Huntington's disease

#2234
20170304343
2017-10-26

Antibodies specific for LOX1 and use in treatment of cardiovascular disorders

#2235
20170299594
2017-10-19

SIGNATURES AND PCDETERMINANTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USE THEREOF

#2236
20170298367
2017-10-19

Auto-inducible expression system

#2237
20170298364
2017-10-19

Fusion protein, nanoparticle composed of a plurality of monomers of said fusion protein, and uses thereof

#2238
20170298127
2017-10-19

Anti-PACAP antibodies and uses thereof

#2239
20170298115
2017-10-19

Humanized anti-PACAP antibodies and uses thereof

#2240
20170298107
2017-10-19

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

#2241
20170298106
2017-10-19

Multivalent and monovalent multispecific complexes and their uses

#2242
20170298105
2017-10-19

Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist

#2243
20170295821
2017-10-19

ISOLATION OF SOLUBLE PROTEINS FROM AGGREGATED CASEIN-CONTAINING MIXTURES

#2244
20170295762
2017-10-19

Methods and compositions for generating a mouse

#2245
20170291953
2017-10-12

Car expression vector and car-expressing T cells

#2246
20170291939
2017-10-12

ANTIBODIES SPECIFIC FOR IL-17A FUSED TO HYALURONAN BINDING PEPTIDE TAGS

#2247
20170291938
2017-10-12

Production cell line enhancers

#2248
20170290922
2017-10-12

Activation of adaptive immune processes for the treatment of cancers and infectious diseases

#2249
20170290308
2017-10-12

Rodents having a humanized TMPRSS gene

#2250
20170283851
2017-10-05

Resonance energy transfer assay with cleavage sequence and spacer

#2251
20170283482
2017-10-05

Chimeric Receptors with 4-1BB Stimulatory Signaling Domain

#2252
20170283476
2017-10-05

MYC NUCLEIC ACIDS AND USES THEREOF

#2253
20170283475
2017-10-05

Cancer vaccine compositions and methods of use thereof

#2254
20170282095
2017-10-05

Process For Isolation of Plasma or Serum Proteins

#2255
20170281711
2017-10-05

Activin type 2 receptor antibodies

#2256
20170281686
2017-10-05

BONE MARROW STROMAL CELL DERIVED EXTRACELLULAR MATRIX PROTEIN EXTRACT AND USES THEREOF

#2257
20170275378
2017-09-28

Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase

#2258
20170275343
2017-09-28

Nucleic acids, vectors, host cells, and methods for recombinantly producing water-soluble membrane proteins

#2259
20170275342
2017-09-28

PROTEIN SCAFFOLDS FOR ANTIBODY MIMICS AND OTHER BINDING PROTEINS

#2260
20170275341
2017-09-28

Ubiquitin variant modulators of HECT E3 ligases and their uses

#2261
20170275333
2017-09-28

NOVEL PEPTIDE COMPOSITIONS

#2262
20170274075
2017-09-28

Therapeutic and research application of PDCL3

#2263
20170269070
2017-09-21

Synthetic bi-epitope compound

#2264
20170267763
2017-09-21

Method of treating CD155 expressing cancers

#2265
20170267733
2017-09-21

Novel Read-Through Fusion Polynucleotides and Polypeptides and Uses Thereof

#2266
20170267732
2017-09-21

Compositions and methods for the delivery of oxygen

#2267
20170260529
2017-09-14

POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELING

#2268
20170260290
2017-09-14

Humanized monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase

#2269
20170260256
2017-09-14

Modified colostrum protein and application thereof

#2270
20170260244
2017-09-14

Endoplasmic Reticulum Localization Signals

#2271
20170260235
2017-09-14

POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF

#2272
20170258834
2017-09-14

FGL2 Expressing Regulatory T Cells

#2273
20170254815
2017-09-07

Neprilysin as heart failure prognostic marker

#2274
20170253929
2017-09-07

Homeobox gene

#2275
20170253889
2017-09-07

Promoter and regulatory elements for improved expression of heterologous genes in host cells

#2276
20170253641
2017-09-07

Medicament for Atrophy Treatment or Increasing Cell Growth

#2277
20170252376
2017-09-07

NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE

#2278
20170251645
2017-09-07

REGULATION OF ENDOGENOUS GENE EXPRESSION IN CELLS USING ZINC FINGER PROTEINS

#2279
20170247672
2017-08-31

Method for efficient delivery of therapeutic molecules in vitro and in vivo

#2280
20170247423
2017-08-31

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#2281
20170246119
2017-08-31

Cell-free methods of producing vault particles and vault particles resulting therefrom

#2282
20170242026
2017-08-24

Methods and tools for detecting interactions in eukaryotic cells using microtubule structures and dynamics

#2283
20170242009
2017-08-24

CSN5 polypeptides and uses thereof for screening therapeutic agents

#2284
20170240611
2017-08-24

Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural Disorders

#2285
20170233706
2017-08-17

Chimeric antibacterial polypeptides

#2286
20170233443
2017-08-17

CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE

#2287
20170233442
2017-08-17

Peptidylic inhibitors of nucleolin (NCL) targeting CAG-repeat RNA toxicity and methods for reducing polyQ-mediated toxicity in polyQ diseases

#2288
20170233434
2017-08-17

Method for separating proteins from animal or human plasma, or plants, using a pH gradient method

#2289
20170231204
2017-08-17

Pig model for diabetes

#2290
20170226170
2017-08-10

Calbindin and BH3 domain chimeric proteins and methods for use

#2291
20170226167
2017-08-10

MODIFIED PEPTIDES AND THEIR USE FOR TREATING AUTOIMMUNE DISEASES

#2292
20170224779
2017-08-10

Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone

#2293
20170224770
2017-08-10

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

#2294
20170219603
2017-08-03

Application of TRPM8 protein, related peptide fragment and their antibodies

#2295
20170219602
2017-08-03

Allergen

#2296
20170218047
2017-08-03

NOVEL FUSION PARTNERS FOR THE PURPOSE OF CRYSTALLIZING G-PROTEIN COUPLED RECEPTORS

#2297
20170218035
2017-08-03

COMPOSITIONS AND METHODS FOR TREATMENT WITH HEMOPEXIN

#2298
20170216458
2017-08-03

INTRATHECAL DELIVERY OF RECOMBINANT ADENO-ASSOCIATED VIRUS 9

#2299
20170211089
2017-07-27

Sugar transporters

#2300
20170210818
2017-07-27

CONSTANT REGION ANTIBODY FUSION PROTEINS AND COMPOSITIONS THEREOF

#2301
20170210800
2017-07-27

Methods for improving cardiac function by administering an antibody that activates APLNR

#2302
20170210783
2017-07-27

Composition containing SMAD protein for treatment of autoimmune diseases, a fusion protein comprising SMAD protein, an expression vector and a method for preparing the same

#2303
20170210782
2017-07-27

Peptides for the specific binding of RNA targets

#2304
20170204382
2017-07-20

Methods of identifying ActRIIB variants

#2305
20170202946
2017-07-20

Stabilized influenza hemagglutinin stem region trimers and uses thereof

#2306
20170202784
2017-07-20

CONFIGURABLE CLATHRIN LIGHT CHAIN COMPOSITION

#2307
20170199202
2017-07-13

Marker sequences for diagnosing and stratifying systemic sclerosis patients

#2308
20170198033
2017-07-13

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

#2309
20170198027
2017-07-13

PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS

#2310
20170198020
2017-07-13

NUCLEOTIDE REPEAT EXPANSION-ASSOCIATED POLYPEPTIDES AND USES THEREOF

#2311
20170198019
2017-07-13

CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF

#2312
20170198018
2017-07-13

HCBI, MSBI, MSSI AND CMI SEQUENCES AS AN EARLY MARKER FOR THE FUTURE DEVELOPMENT OF CANCER AND DISEASES OF THE CNS AND AS A TARGET FOR THE TREATMENT AND PREVENTION OF THESE DISEASES

#2313
20170197011
2017-07-13

METHODS FOR REPAIRING CARTILAGE DAMAGE

#2314
20170196956
2017-07-13

KIF20A epitope peptides for TH1 cells and vaccines containing the same

#2315
20170191058
2017-07-06

PERFORIN 2 DEFENSE AGAINST INVASIVE AND MULTIDRUG RESISTANT PATHOGENS

#2316
20170190761
2017-07-06

Methods of treating cancer by administering IGF-IR binding molecules

#2317
20170190754
2017-07-06

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#2318
20170190752
2017-07-06

E1-MINUS ADENOVIRUSES AND USE THEREOF

#2319
20170190751
2017-07-06

Mutant NGAL proteins and uses thereof

#2320
20170190750
2017-07-06

Peptide for Protection of Allergic Respiratory Disorders

#2321
20170189513
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2322
20170189512
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2323
20170189511
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2324
20170189510
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2325
20170189506
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2326
20170189505
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2327
20170189503
2017-07-06

PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same

#2328
20170189482
2017-07-06

Mutant NGAL proteins and uses thereof

#2329
20170183392
2017-06-29

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#2330
20170183387
2017-06-29

METHODS AND COMPOSITIONS FOR SUPPRESSING RETROVIRUSES

#2331
20170182120
2017-06-29

Method of preventing polycystic kidney disease and PKD animal model with exogenous neutrophil gelatinase-associated lipocalin

#2332
20170174790
2017-06-22

Internalizing moieties

#2333
20170174745
2017-06-22

Multivalent heteromultimer scaffold design and constructs

#2334
20170173152
2017-06-22

Antibody to mucin 4 (MUC4) glycopeptide and uses thereof

#2335
20170166943
2017-06-15

Oligosaccharide modification and labeling of proteins

#2336
20170166892
2017-06-15

Methods for the treatment of cardiovascular fibrosis

#2337
20170166631
2017-06-15

Human derived anti-Huntingtin (HTT) antibodies and uses thereof

#2338
20170166616
2017-06-15

Chimeric inhibitor molecules of complement activation

#2339
20170166615
2017-06-15

Proteins specific for calcitonin gene-related peptide

#2340
20170165340
2017-06-15

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#2341
20170165338
2017-06-15

Peptides and combination of peptides for use in immunotherapy against various cancers

#2342
20170165334
2017-06-15

Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification

#2343
20170159096
2017-06-08

METHOD FOR FUSION EXPRESSION OF ION CHANNEL PROTEIN AND TRANSPORT PROTEIN AND PROTEIN FRAGMENT USED THEREFOR

#2344
20170159093
2017-06-08

Modification of RNA-related enzymes for enhanced production

#2345
20170158750
2017-06-08

Peptides and combination of peptides for use in immunotherapy against various tumors

#2346
20170158744
2017-06-08

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#2347
20170157269
2017-06-08

OPTOGENETIC CONTROL OF REWARD-RELATED BEHAVIORS

#2348
20170157217
2017-06-08

Use of endostatin peptides for the treatment of fibrosis

#2349
20170157212
2017-06-08

CDK MODULATORS AND METHODS FOR THE TREATMENT OF CANCER

#2350
20170153252
2017-06-01

Methods and kits for detecting brain injury

#2351
20170152295
2017-06-01

Calcium reporter gene

#2352
20170145380
2017-05-25

Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions

#2353
20170145081
2017-05-25

EHD2 Antibody and Application Thereof in Preparation of Immunohistochemical Detection Reagent for Breast Cancer

#2354
20170145073
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#2355
20170145072
2017-05-25

Peptides and combination of peptides for use in immunotherapy against various tumors

#2356
20170143986
2017-05-25

System utilizing light-activated ion channel protein (VChR1) for optical stimulation of target cells

#2357
20170143798
2017-05-25

Modulation of cellular stress using a B-cell oxidative and/or endoplasmic reticulum stress inhibitor and a targeting agent

#2358
20170143797
2017-05-25

Vault complexes for cytokine delivery

#2359
20170137494
2017-05-18

Fibronectin binding domains with reduced immunogenicity

#2360
20170137478
2017-05-18

Mps1 and KNL1 phosphorylation system

#2361
20170137467
2017-05-18

Epitope tag and method for detection and/or purification of tagged polypeptides

#2362
20170137464
2017-05-18

Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides

#2363
20170130272
2017-05-11

A Diagnostic Marker For Paget's Disease

#2364
20170129944
2017-05-11

METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN

#2365
20170129934
2017-05-11

Natriuretic polypeptides

#2366
20170128536
2017-05-11

Pharmaceutical compositions and their use for the treatment of autoimmune disorders

#2367
20170128528
2017-05-11

Modified Friedreich ataxia genes and vectors for gene therapy

#2368
20170121381
2017-05-04

Peptides for the treatment of neurodegenerative diseases

#2369
20170121380
2017-05-04

Composition for preventing or treating fatty liver or insulin resistance syndrome including extracellular domain of delta-like 1 homolog

#2370
20170121379
2017-05-04

USING B-CELL-TARGETING ANTIGEN IGG FUSION AS TOLEROGENIC PROTEIN THERAPY FOR TREATING ADVERSE IMMUNE RESPONSES

#2371
20170119900
2017-05-04

Peptide, complex of peptide and siRNA and use thereof

#2372
20170115296
2017-04-27

Method for the detection of cancer cells by localization of peptides in nucleus as compared to cytoplasm

#2373
20170114412
2017-04-27

Method for treating kidney disease with a SLIT2-binding extracellular domain of ROBO2

#2374
20170114143
2017-04-27

Neutralizing antibodies and methods of use thereof

#2375
20170114109
2017-04-27

Muteins of human lipocalin 2 (Lcn2,hNGAL) with affinity for a given target

#2376
20170114108
2017-04-27

Genetically encoded histone reporter allele constructs

#2377
20170114104
2017-04-27

Monomeric avidin-like proteins with stable biotin binding ability

#2378
20170107540
2017-04-20

Method of genetically altering and producing allergy free cats

#2379
20170107271
2017-04-20

Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)

#2380
20170107266
2017-04-20

Specific-binding polypeptides and uses thereof

#2381
20170107265
2017-04-20

Met e 1 tropomyosin variants for use in allergen-specific immunotherapy

#2382
20170107255
2017-04-20

Apelin polypeptides

#2383
20170100454
2017-04-13

Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders

#2384
20170097366
2017-04-06

Development and use of fluorescent probes of unbound bilirubin

#2385
20170096469
2017-04-06

Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue

#2386
20170096460
2017-04-06

HTT repressors and uses thereof

#2387
20170095556
2017-04-06

Engineered light-activated anion channel proteins and methods of use thereof

#2388
20170089929
2017-03-30

Antibodies to TTR and Methods of Use

#2389
20170088857
2017-03-30

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

#2390
20170087246
2017-03-30

Modular antigen transportation molecules and uses thereof in animals

#2391
20170087185
2017-03-30

Genetic engineering of macrophages for immunotherapy

#2392
20170082619
2017-03-23

Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens

#2393
20170081386
2017-03-23

GITRL-collectin fusion proteins and encoding nucleic acids

#2394
20170081375
2017-03-23

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, RENAL NEPHRONS AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

#2395
20170081374
2017-03-23

TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS

#2396
20170081359
2017-03-23

SOLID PHASE PEPTIDE SYNTHESIS METHODS AND ASSOCIATED SYSTEMS

#2397
20170081358
2017-03-23

Methods and systems for solid phase peptide synthesis

#2398
20170080060
2017-03-23

Methods of delivering a polypeptide molecule to Otx2 target cells using an Otx2 targeting peptide

#2399
20170073682
2017-03-16

Binding-induced DNA nanomachines

#2400
20170073423
2017-03-16

Method of engineering multi-input signal sensitive T cell for immunotherapy